TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 5 filers reported holding TRANSENTERIX INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $129,000 | -34.8% | 208,600 | +38.3% | 0.01% | -40.9% |
| Q2 2019 | $198,000 | +1.5% | 150,800 | +84.4% | 0.02% | -43.6% |
| Q4 2018 | $195,000 | -55.2% | 81,800 | +9.4% | 0.04% | -51.9% |
| Q3 2018 | $435,000 | +23.2% | 74,800 | -13.0% | 0.08% | +68.8% |
| Q2 2018 | $353,000 | +854.1% | 86,000 | +290.9% | 0.05% | +860.0% |
| Q1 2018 | $37,000 | -31.5% | 22,000 | -12.0% | 0.01% | -37.5% |
| Q4 2017 | $54,000 | +86.2% | 25,000 | +31.6% | 0.01% | +100.0% |
| Q3 2017 | $29,000 | -73.9% | 19,000 | -26.9% | 0.00% | -84.0% |
| Q1 2016 | $111,000 | – | 26,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 7,546,692 | $12,829,000 | 9.62% |
| StepStone Group LP | 3,032,625 | $5,155,000 | 3.79% |
| Aisling Capital LLC | 9,889,352 | $16,812,000 | 3.00% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 519,548 | $883,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,503,000 | 0.59% |
| MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $6,800,000 | 0.15% |
| Tibra Equities Europe Ltd | 335,565 | $570,000 | 0.10% |
| BRANDYWINE MANAGERS, LLC | 94,583 | $161,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 513,430 | $872,000 | 0.05% |
| ACUTA CAPITAL PARTNERS, LLC | 180,000 | $307,000 | 0.05% |